Mobile Menu

Biotechnology in the UK - Market Research Report (2014-2029)

Lawrence Thomas Lawrence Thomas London, United Kingdom Last Updated: December 2024 SIC M72.110

Revenue

£23.4bn

2024-25

£23.4bn

Past 5-Year Growth

Profit

£X.Xbn

Employees

101k

Businesses

3,110

Wages

£X.Xbn

Biotechnology in the UK industry analysis

Over the five years through 2024-25, biotechnology revenue is forecast to climb at a compound annual rate of 8.1% to £23.4 billion. Biotechnology can make agriculture more efficient and sustainable, broadening its appeal and economic value. It’s fast becoming a prominent part of the UK life science sector, alongside pharmaceutical and medical technology. The convergence of these three technologies makes it increasingly difficult to identify the boundaries between them. Even so, high demand for biotechnology products that help solve medical, agricultural and industrial issues has contributed to strong revenue growth.

Trends and Insights

  • The government encourages R&D activity, offering funding to start-ups. The industry has received significant public-sector backing, boosting confidence in its security and growth.
  • The agricultural and food sectors offer a growing market. Companies in these sectors seek crop seeds that produce greater yields and are more resilient, as well as animal health products.
  • Biotech companies tend to set up shop near universities to aid collaboration. Public spending on R&D is concentrated, with 40% spent in the so-called Golden Triangle between Oxford, Cambridge and London.
  • The UK faces steep competition from the US and China. The UK is unable to attract the same capital as other countries, but UK biotechnology companies hold a stronger footing owing to substantial investment from the government.

Access hundreds of analysis and data

  • Market estimates from 2014-2029
  • Critical performance data and rankings
  • Detailed analysis of competitive forces and the external environment
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Industry Statistics and Trends

Market size and recent performance (2014-2029)

Industry revenue has grown at a CAGR of 8.5 % over the past five years, to reach an estimated £23.4bn in 2024.

Trends and Insights

The industry remains heavily dependent on external investment

  • The initial hit to private investment caused by the pandemic was more than mitigated by the industry's need to research diagnostic techniques and cures for the virus. UK biotech companies reaped the rewards of the hike in government spending to aid vaccine development. For example, the government spent £544 million on finding a vaccine and producing antibody kits. In October 2023, UK Research and Innovation allocated £25 million to several projects aimed at improving the understanding of infectious diseases and developing advanced vaccines. Swelling funding for vaccine development and better testing elevated revenue for UK biotech companies.
  • Additional trends and insights available with purchase
Biotechnology in the UK
Revenue (2014-2029)
IBISWorld Logo Source: IBISWorld

Industry outlook (2024-2029)

Market size is projected to grow over the next five years.

Trends and Insights

The UK's aim to boost its economic presence creates opportunities for biotech companies

  • The UK government will continue to invest heavily in the Biotechnology industry to boost the UK's global presence. In December 2023, through the Science Minister, the UK government announced a national vision for biology, setting out a £2 billion investment plan over the next decade to seize biology's potential to deliver new medical therapies, crop varieties, eco-friendly fuels and chemicals. The investment includes investing in world-class R&D and in the infrastructure needed to boost innovation and scale it up. Many biotech businesses are set to benefit from this investment plan and will support the industry through much-needed funding and infrastructure, spurring growth opportunities and fuelling revenue growth.

Biggest companies in the Biotechnology in the UK

Company
Market Share (%)
2025
Revenue (£m)
2025
Amgen Ltd
319.0
BTG Ltd
265.3
Oxford Nanopore Technologies plc
205.8

To view the market share and analysis for all 4 top companies in this industry, view purchase options.

Products & Services Segmentation

Biotechnology in the UK
Products & Services
IBISWorld Logo Source: IBISWorld

Industry revenue is measured across several distinct product and services lines, including Human health products, Agriculture and food-enhancement products and Animal health products. Human health products is the largest segment of the Biotechnology in the UK.

Trends and Insights

The development of human health products benefits from increased funding

  • Human health products include therapeutics like biotechnology-derived proteins, antibodies and enzymes; genetic therapies and diagnostics; and tests for specific genetic or protein markers.
  • More insights available in the full report

Table of Contents

About this industry

Industry definition

Biotechnology uses scientific principles to create technological applications using biological systems, living organisms or derivatives to make or modify products or processes. The industry focuses on medicinal, industrial and agricultural biotechnology applications.

What's included in this industry?

Human health productsAgriculture and food-enhancement productsAnimal health productsEnvironmental remediation and resource efficiency services Outsourced biotechnology services

Companies

Amgen LtdBTG LtdOxford Nanopore Technologies plc

Purchase this report to view all 4 major companies in this industry.

Related Terms

GENETIC MODIFICATIONPHARMACOGENOMICSBIOPHARMACEUTICALBIOSIMILAR

Industry Code

SIC 2007

SIC 72.11 - Biotechnology in the UK

Performance

Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.

Analyst insights

The government encourages R&D activity, offering funding to start-ups. The industry has received significant public-sector backing, boosting confidence in its security and gr...

In this chapter (4)

  • Current Performance
  • Outlook
  • Volatility
  • Life Cycle

Key metrics

  • Annual Revenue, Recent Growth, Forecast, Revenue Volatility
  • Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
  • Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
  • Total Profit, Profit Margin, Profit per Business

Charts

  • Revenue, including historical (2014-2023) and forecast (2024-2029)
  • Employees, including historical (2014-2023) and forecast (2024-2029)
  • Businesses, including historical (2014-2023) and forecast (2024-2029)
  • Profit, including historical (2014-2024)
  • Industry Volatility vs. Revenue Growth
  • Industry Life Cycle

Detailed analysis

  • Trends in supply, demand and current events that are driving current industry performance
  • Expected trends, economic factors and ongoing events that drive the industry's outlook
  • Key success factors for businesses to overcome volatility
  • How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.

Products and Markets

Learn about an industry's products and services, markets and trends in international trade.

Analyst insight

The agricultural and food sectors offer a growing market. Companies in these sectors seek crop seeds that produce greater yields and are more resilient, as well as animal hea...

In this chapter

  • Products & Services
  • Major Markets

Key metrics

  • Largest market segment and value in 2024
  • Product innovation level

Charts

  • Products & services segmentation in 2024
  • Major market segmentation in 2024

Detailed analysis

  • Trends impacting the recent performance of the industry's various segments
  • Innovations in the industry's product or service offering, specialization or delivery method
  • Key factors that successful businesses consider in their offerings
  • Buying segments and key trends influencing demand for industry products and services

Geographic Breakdown

Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.

Analyst insights

Biotech companies tend to set up shop near universities to aid collaboration. Public spending on R&D is concentrated, with 40% spent in the so-called Golden Triangle between ...

In this chapter (1)

  • Business Locations

Charts

  • Share of revenue, establishment, wages and employment in each region
  • Share of population compared to establishments in each region in 2024

Tables

  • Number and share of establishments in each region in 2024
  • Number and share of revenue each region accounts for in 2024
  • Number and share of wages each region accounts for in 2024
  • Number and share of employees in each region in 2024

Detailed analysis

  • Geographic spread of the industry across Europe, and trends associated with changes in the business landscape
  • Key success factors for businesses to use location to their advantage

Competitive Forces

Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.

Analyst insights

The UK faces steep competition from the US and China. The UK is unable to attract the same capital as other countries, but UK biotechnology companies hold a stronger footing ...

In this chapter (4)

  • Concentration
  • Barriers to Entry
  • Substitutes
  • Buyer & Supplier Analysis

Key metrics

  • Industry concentration level
  • Industry competition level and trend
  • Barriers to entry level and trend
  • Substitutes level and trend
  • Buyer power level and trend
  • Supplier power level and trend

Charts

  • Market share concentration among the top 4 suppliers from 2019-2024
  • Supply chain including upstream supplying industries and downstream buying industries, flow chart

Detailed analysis

  • Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
  • Key success factors for businesses to manage the competitive environment of the industry.
  • Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
  • Key success factors for potential entrants to overcome barriers to entry.
  • Competitive threats from potential substitutes for the industry’s own products and services.
  • Key success factors for how successful businesses can compete with substitutes.
  • Advantages that buyers have to keep favorable purchasing conditions.
  • Advantages that suppliers have to maintain favorable selling conditions.
  • Key success factors for how businesses can navigate buyer and supplier power.

Companies

Learn about the performance of the top companies in the industry.

Analyst insights

No company has a market share greater than 5%. The industry consists of a large number of small, highly specialised research companies that are heavily reliant on funding fro...

In this chapter

  • Market Share Concentration
  • Companies
  • Company Spotlights

Charts

  • Industry market share by company in 2020 through 2024
  • Major companies in the industry, including market share, revenue, profit and profit margin in 2024
  • Overview of Amgen Ltd's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of BTG Ltd's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of Oxford Nanopore Technologies plc's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of revenue, market share and profit margin trend for one additional company

Detailed analysis

  • Description and key data for Amgen Ltd, and factors influencing its performance in the industry
  • Description and key data for BTG Ltd, and factors influencing its performance in the industry
  • Description and key data for Oxford Nanopore Technologies plc, and factors influencing its performance in the industry
  • Description, key data and performance trends for one additional company

External Environment

Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.   

Analyst insights

Ethical concerns plague progress. Strict regulations are enforced on biotechnology companies, mostly related to stem cell research, cloning and genetic modification.

In this chapter

  • External Drivers
  • Regulation & Policy
  • Assistance

Key metrics

  • Regulation & policy level and trend
  • Assistance level and trend

Charts

  • Regulation & Policy historical data and forecast (2014-2029) 
  • Assistance historical data and forecast (2014-2029) 

Detailed analysis

  • Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
  • Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
  • Key governmental and non-governmental groups or policies that may provide some relief for industry operators.

Financial Benchmarks

View average costs for industry operators and compare financial data against an industry's financial benchmarks over time. 

Analyst insights

Maturing biotech companies prop up profitability. Maturing companies bringing new products to market, generating healthy royalties and researching future products drive profi...

In this chapter

  • Cost Structure
  • Financial Ratios
  • Key Ratios

Key metrics

  • Profit margin, and how it compares to the sector-wide margin
  • Average wages, and how it compares to the sector-wide average wage
  • Largest cost component as a percentage of revenue
  • Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio

Charts

  • Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Investment vs. share of economy

Data tables

  • Liquidity Ratios (2018-2022)
  • Coverage Ratios (2018-2022)
  • Leverage Ratios  (2018-2022)
  • Operating Ratios (2018-2022)
  • Assets (2018-2022)
  • Liabilities (2018-2022)
  • Cash Flow & Debt Service Ratios (2014-2029)
  • Revenue per Employee (2014-2029)
  • Revenue per Enterprise (2014-2029)
  • Employees per Establishment (2014-2029)
  • Employees per Enterprise (2014-2029)
  • Average Wage (2014-2029)
  • Wages/Revenue (2014-2029)
  • Establishments per Enterprise (2014-2029)
  • IVA/Revenue (2014-2029)
  • Imports/Demand (2014-2029)
  • Exports/Revenue (2014-2029)

Detailed analysis

  • Trends in the cost component for industry operators and their impact on industry costs and profitability 

Key Statistics

Industry Data

Data Tables

Including values and annual change:

  • Revenue (2014-2029)
  • IVA (2014-2029)
  • Establishments (2014-2029)
  • Enterprises (2014-2029)
  • Employment (2014-2029)
  • Exports (2014-2029)
  • Imports (2014-2029)
  • Wages (2014-2029)

Top Questions Answered

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Biotechnology in the UK industry in United Kingdom in 2024?

The market size of the Biotechnology in the UK industry in United Kingdom is £23.4bn in 2024.

How many businesses are there in the Biotechnology in the UK industry in 2024?

There are 3,110 businesses in the Biotechnology in the UK industry in United Kingdom, which has grown at a CAGR of 7.3 % between 2019 and 2024.

Has the Biotechnology in the UK industry in United Kingdom grown or declined over the past 5 years?

The market size of the Biotechnology in the UK industry in United Kingdom has been growing at a CAGR of 8.5 % between 2019 and 2024.

What is the forecast growth of the Biotechnology in the UK industry in United Kingdom over the next 5 years?

Over the next five years, the Biotechnology in the UK industry in United Kingdom is expected to grow.

What are the biggest companies in the Biotechnology in the UK market in United Kingdom?

The biggest companies operating in the Biotechnology market in United Kingdom are Amgen Ltd, BTG Ltd and Oxford Nanopore Technologies plc

What does the Biotechnology in the UK in United Kingdom include?

Human health products and Agriculture and food-enhancement products are part of the Biotechnology in the UK industry.

Which companies have the highest market share in the Biotechnology in the UK in United Kingdom?

The company holding the most market share in United Kingdom is Amgen Ltd.

How competitive is the Biotechnology in the UK industry in United Kingdom?

The level of competition is moderate and increasing in the Biotechnology in the UK industry in United Kingdom.

Related Industries

Widen your competitive advantage with related industries

Competitors

  • Universities in the UK

Complementors

  • Pesticide & Other Agrochemical Manufacturing in the UK
  • Basic Pharmaceutical Product Manufacturing in the UK
  • Pharmaceutical Preparations Manufacturing in the UK

International industries

  • Global Biotechnology
  • Scientific Research & Development in the US
  • Animal Health Biotechnology in the US
  • DNA & DNA Forensic Laboratories in the US
  • Contract Pharmaceutical Research Services in the US

View all industries in United Kingdom

Methodology

How are IBISWorld reports created?

IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.

Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.

IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.

What data sources do IBISWorld analysts use?

Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.

Key data sources in the UK include:

  • Office for National Statistics
  • Office for Budget Responsibility
  • Bank of England

Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.

These sources include:

  • Industry and trade associations
  • Industry federations or regulators
  • Major industry players annual or quarterly filings

Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.

How does IBISWorld forecast its data?

IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.

IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.

Learn more about our methodology and data sourcing on the Help Center.